Type
Merger/Acquisition
Country
France
Region
Centre-Est; Rhône-Alpes; Rhône
Location of affected unit(s)
Saint-Genis-Laval
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.10 - Manufacture of basic pharmaceutical products

207 jobs
Number of planned job losses
Job loss
Announcement Date
20 July 2020
Employment effect (start)
27 July 2020
Foreseen end date
31 December 2020

Description

The Commercial Court of Paris has given the go-ahead for the takeover of the Famar Lyon site by Benta Pharma Industries. The buyer announces the safeguarding of 115 employees out of 240 (at the time it was put up for sale, the site employed 322 people).

There should be prospects for new hires in th future; by 2026, the group plans to employ a total of 270 people on the site, where medicines such as Nivaquine (chloroquine sulphate) are produced. The investment amounts to €42 million over six years. 'It's always better than liquidation', says Famar Lyon's CGT representative. Still, there will be more redundancies than employees maintained. Keeping a pharmaceutical activity in Saint-Genis-Laval was our battle horse'. In particular, the site is specialised in the manufacture of medicines for bipolar people.  


Sources

Citation

Eurofound (2020), Famar, Merger/Acquisition in France, factsheet number 101300, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101300.